Add to ORKGA well-powered clinical trial that failed to replicate promising results in animal models of fragile X syndrome yields important lessons for clinical trial design (Berry-Kravis et al., this issue)
Tori L Schaefer, Matthew H Davenport, Craig A Erickson Division of Child and Adolescent Psychiatry, ...
Many available drugs have been repurposed as treatments for neurodevelopmental disorders. In the spe...
Fragile X Syndrome (FXS) is one of the most prevalent and well-studied monogenetic causes of intelle...
A well-powered clinical trial that failed to replicate promising results in animal models of fragile...
Neurodevelopmental disorders such as fragile X syndrome (FXS) result in lifelong cognitive and behav...
Neurodevelopmental disorders such as fragile X syndrome (FXS) result in lifelong cognitive and behav...
ObjectiveProgress in basic neuroscience has led to identification of molecular targets for treatment...
OBJECTIVE: Progress in basic neuroscience has led to identification of molecular targets for treatme...
Our understanding of fragile X syndrome (FXS) pathophysiology continues to improve and numerous pote...
Preclinical studies using animal models of fragile X syndrome have yielded several agents that rescu...
Rationale: Advances in understanding the underlying mechanisms of conditions such as fragile X syndr...
Abstract Our understanding of fragile X syndrome (FXS) pathophysiology continues to improve and nume...
Fragile X syndrome (FXS), the most common monogenetic cause of intellectual disability and autism sp...
Preclinical studies using animal models of fragile X syndrome have yielded several agents that rescu...
Fragile X syndrome (FXS) is the most common single-gene cause of intellectual disability and autism ...
Tori L Schaefer, Matthew H Davenport, Craig A Erickson Division of Child and Adolescent Psychiatry, ...
Many available drugs have been repurposed as treatments for neurodevelopmental disorders. In the spe...
Fragile X Syndrome (FXS) is one of the most prevalent and well-studied monogenetic causes of intelle...
A well-powered clinical trial that failed to replicate promising results in animal models of fragile...
Neurodevelopmental disorders such as fragile X syndrome (FXS) result in lifelong cognitive and behav...
Neurodevelopmental disorders such as fragile X syndrome (FXS) result in lifelong cognitive and behav...
ObjectiveProgress in basic neuroscience has led to identification of molecular targets for treatment...
OBJECTIVE: Progress in basic neuroscience has led to identification of molecular targets for treatme...
Our understanding of fragile X syndrome (FXS) pathophysiology continues to improve and numerous pote...
Preclinical studies using animal models of fragile X syndrome have yielded several agents that rescu...
Rationale: Advances in understanding the underlying mechanisms of conditions such as fragile X syndr...
Abstract Our understanding of fragile X syndrome (FXS) pathophysiology continues to improve and nume...
Fragile X syndrome (FXS), the most common monogenetic cause of intellectual disability and autism sp...
Preclinical studies using animal models of fragile X syndrome have yielded several agents that rescu...
Fragile X syndrome (FXS) is the most common single-gene cause of intellectual disability and autism ...
Tori L Schaefer, Matthew H Davenport, Craig A Erickson Division of Child and Adolescent Psychiatry, ...
Many available drugs have been repurposed as treatments for neurodevelopmental disorders. In the spe...
Fragile X Syndrome (FXS) is one of the most prevalent and well-studied monogenetic causes of intelle...